The thermal modeling for the redesign of an X-Ray Spectrometer (XRS) High Tc Superconducting Current (HTSC) lead assembly was the objective of this research work. In order to achieve a 2.5-year lifetime for the XRS, low thermal conductance leads were redesign to supply electric current to the Adiabatic Demagnetization Refrigerator (ADR) magnet and the cryostat valve motors with a minimal heat load. This research work consisted of the development of a mockup of the HTSC lead assembly and a computer model to simulate the thermal behavior of the system. Experimental data of the mockup was used to validate the thermal model, which was employed in the optimization of the design to minimize the heat load. The thermal model development and validation of the new HTSC lead design is discussed, with emphasis on thermal test results.
Diabetics have a greater predisposition for developing cerebral vasospasms (CVSPs) than nondiabetics, even when under glycemic control. The etiology of CVSPs is associated with increased vascular tone, secondary to augmented intracellular Ca+2 in vascular smooth muscle. Current pharmacological treatments are ineffective in reducing CVSPs. The combination of the ryanodine receptor blocker dantrolene (50 μM) and the Ca+2 channel blocker nimodipine significantly decreases vascular reactivity in streptozotocin (STZ)‐induced diabetic rats. In order to determine if the beneficial effects observed at 50 μM are also maintained at a much lower concentration with less potentially harmful secondary effects, we evaluated the vascular effects of 10 μM dantrolene, alone and in combination with 50 nM nimodipine. Dose‐response curves for the phenylephrine (PHE)‐induced contraction (0.1 nM to 10 μM) and acetylcholine (ACh)‐induced relaxation (1 nM to 10 μM) were performed on aortic rings from STZ‐diabetic rats, both before and after a 30‐minute incubation period with dantrolene alone or in combination with nimodipine. Whereas 50 μM dantrolene reduced PHE‐induced contraction by 47% in diabetic rats and 29% in controls, 10 μM dantrolene failed to reduce this parameter in either group. Moreover, 50 μM dantrolene reduced PHE‐induced contraction by about 80% in both diabetic and controls when combined with nimodipine. The combination of 10 μM dantrolene and nimodipine, however, does not increase the reduction of 35% in diabetic rats and 47% in controls obtained with nimodipine alone. In addition, only 50 μM dantrolene increased ACh‐induced relaxation by 50% (N=9, P<0.05) in diabetic rats. These results suggest that both, improved endothelial‐dependent relaxation and reduced vascular contraction with dantrolene are dosedependent. Thus, careful titration should be performed in order to achieve a significant reduction in hyper‐reactivity in both diabetics and nondiabetics.Support or Funding InformationThis work was supported by Grants from the National Institute of Health (MBRS‐RISE Grant R25GM061838), the NIMHD‐RCMI Program (Grant G12‐MD007600), and the Anesthesiology Department of the University of Puerto Rico‐School of Medicine.This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.